Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00269763Phase 3Completed
Phase 3, open-label, single-arm trial of fentanyl in cancer pain, sponsored by ALZA Corporation. Primary endpoints: Assessment of pain relief and Rescue medication usage. Started Oct 1987; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00269763.